FMR LLC — SEC insider filings

SEC reporting owner CIK 315066. 62 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers the 50 most recent of 62 filings on record, filed 2021-10-28 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Beam Therapeutics Inc. (BEAM)10% owner9—15 legs · 1,275,601 sh · $40,829,35818
Verve Therapeutics, Inc. (VERV)—8—14 legs · 466,565 sh · $11,296,477—
Fidelity Private Credit Fund—33 legs · 347,506 sh · $8,767,813——
Avalyn Pharma Inc. (AVLN)10% owner2—4 legs · 228,454 sh · $6,701,00410
Sana Biotechnology, Inc. (SANA)10% owner1—4 legs · 290,912 sh · $1,887,320—
Metsera, Inc. (MTSR)10% owner7—2 legs · 461 sh · $21,46523
Structure Therapeutics Inc. (GPCR)10% owner13——49
Turnstone Biologics Corp. (TSBX)—2——12
Prime Medicine, Inc. (PRME)—1——10
Xilio Therapeutics, Inc. (XLO)—1——10

+3 more issuers among the filings shown — every filing appears in the table below.

Insider filings — FMR LLC

FiledFormIssuerReported transactionsSource
2026-11-124Avalyn Pharma Inc. (AVLN)Sale (S): 173,661 @ $29.06 · Sale (S): 1,339 @ $29.75 · Sale (S): 5,565 @ $29.56 · Sale (S): 47,889 @ $30.28EDGAR
2026-07-244Structure Therapeutics Inc. (GPCR)Sale (S): 1,367 (derivative) @ $50.07 · Sale (S): 16,085 (derivative) @ $50.07EDGAR
2026-06-294Beam Therapeutics Inc. (BEAM)Sale (S): 33,372 @ $35.12 · Sale (S): 251,488 @ $35.26EDGAR
2026-05-054Avalyn Pharma Inc. (AVLN)Conversion (C): 727,585 · Conversion (C): 80,291 · Conversion (C): 872,868 · Conversion (C): 225,843 · Conversion (C): 377,948 · Conversion (C): 727,585 (derivative) · +4 moreEDGAR
2026-04-164Structure Therapeutics Inc. (GPCR)Sale (S): 1,367 (derivative) @ $55.07 · Sale (S): 16,085 (derivative) @ $55.07EDGAR
2026-01-204Structure Therapeutics Inc. (GPCR)Sale (S): 465 (derivative) @ $82.10 · Sale (S): 330 (derivative) @ $83.35 · Sale (S): 552 (derivative) @ $84.22 · Sale (S): 20 (derivative) @ $85.04 · Sale (S): 5,477 (derivative) @ $82.10 · Sale (S): 3,880 (derivative) @ $83.35 · +2 moreEDGAR
2025-12-104Structure Therapeutics Inc. (GPCR)Sale (S): 709 (derivative) @ $92.52 · Sale (S): 183 (derivative) @ $94 · Sale (S): 475 (derivative) @ $94.61 · Sale (S): 1,414 (derivative) @ $61.05 · Sale (S): 1,320 (derivative) @ $61.45 · Sale (S): 8,337 (derivative) @ $92.52 · +4 moreEDGAR
2025-11-174Metsera, Inc. (MTSR)Other (J): 3,010 · Other (J): 2,230,450EDGAR
2025-11-124Metsera, Inc. (MTSR)Gift (G): 860,722 @ $0EDGAR
2025-11-054Metsera, Inc. (MTSR)Other (J): 3,189,540 @ $0 · Other (J): 47,843 @ $0 · Other (J): 47,843 @ $0 · Other (J): 2,115 @ $0 · Other (J): 2,356,274 @ $0 · Sale (S): 193 @ $61.23 · +2 moreEDGAR
2025-10-294Beam Therapeutics Inc. (BEAM)Sale (S): 459 @ $26.68EDGAR
2025-10-084Beam Therapeutics Inc. (BEAM)Gift (G): 1,232,434 @ $0EDGAR
2025-10-084Metsera, Inc. (MTSR)Gift (G): 633,715 @ $0EDGAR
2025-09-124/AMetsera, Inc. (MTSR)Other (J): 1,107,547 @ $0EDGAR
2025-09-044Metsera, Inc. (MTSR)Other (J): 1,350,000 @ $0 · Other (J): 20,250 @ $0 · Other (J): 20,250 @ $0 · Other (J): 895 @ $0 · Other (J): 997,312 @ $0 · Other (J): 997,044 @ $0 · +2 moreEDGAR
2025-08-014Beam Therapeutics Inc. (BEAM)Sale (S): 48,374 @ $20.50EDGAR
2025-08-014Structure Therapeutics Inc. (GPCR)Sale (S): 26,310 (derivative) @ $17.87EDGAR
2025-02-104Structure Therapeutics Inc. (GPCR)Sale (S): 41 (derivative) @ $30.54EDGAR
2025-02-054Metsera, Inc. (MTSR)Conversion (C): 1,418,606 · Conversion (C): 3,120,934 · Conversion (C): 1,418,606 (derivative) · Conversion (C): 3,120,934 (derivative)EDGAR
2025-01-104Sana Biotechnology, Inc. (SANA)Sale (S): 100,000 @ $6.11 · Sale (S): 25,000 @ $6.50 · Sale (S): 164,912 @ $6.71 · Sale (S): 1,000 @ $7.26EDGAR
2024-09-184Bicara Therapeutics Inc. (BCAX)Conversion (C): 10,818 · Conversion (C): 712,430 · Conversion (C): 392,085 · Conversion (C): 10,818 (derivative) · Conversion (C): 712,430 (derivative) · Conversion (C): 392,085 (derivative)EDGAR
2024-04-194Structure Therapeutics Inc. (GPCR)Holdings only — no transactions reportedEDGAR
2024-03-184Structure Therapeutics Inc. (GPCR)Sale (S): 21,997 (derivative) @ $35EDGAR
2024-02-154Beam Therapeutics Inc. (BEAM)Sale (S): 410 @ $30.28 · Sale (S): 1,155 @ $30.93 · Sale (S): 854,323 @ $30.51 · Sale (S): 45,677 @ $31.34EDGAR
2024-02-154Structure Therapeutics Inc. (GPCR)Sale (S): 525 (derivative) @ $47.24EDGAR
2024-01-314Fidelity Private Credit FundHoldings only — no transactions reportedEDGAR
2024-01-114Turnstone Biologics Corp. (TSBX)Holdings only — no transactions reportedEDGAR
2023-12-274Beam Therapeutics Inc. (BEAM)Other (J): 29,549 @ $0EDGAR
2023-12-274Structure Therapeutics Inc. (GPCR)Other (J): 25,410 (derivative) @ $0EDGAR
2023-12-074Structure Therapeutics Inc. (GPCR)Sale (S): 1,368 (derivative) @ $62.46 · Sale (S): 16,086 (derivative) @ $62.46EDGAR
2023-11-294Fidelity Private Credit FundPurchase (P): 391.50 @ $25.54 · Purchase (P): 391.50 @ $25.54EDGAR
2023-10-234Structure Therapeutics Inc. (GPCR)Sale (S): 1,368 (derivative) @ $65.64 · Sale (S): 16,086 (derivative) @ $65.64EDGAR
2023-09-214Neumora Therapeutics, Inc. (NMRA)Conversion (C): 3,475,646 · Conversion (C): 84,965 · Conversion (C): 63,724 · Conversion (C): 88,289 · Conversion (C): 63,724 (derivative) · Conversion (C): 3,475,646 (derivative) · +2 moreEDGAR
2023-07-274Turnstone Biologics Corp. (TSBX)Conversion (C): 91,663 · Conversion (C): 106,496 · Conversion (C): 150,809 · Conversion (C): 483,684 · Conversion (C): 296,396 · Conversion (C): 4,939 · +6 moreEDGAR
2023-06-294Fidelity Private Credit FundPurchase (P): 346,722.78 @ $25.23EDGAR
2023-02-094Structure Therapeutics Inc. (GPCR)Conversion (C): 965,115 · Conversion (C): 57,523 · Conversion (C): 10,154 · Conversion (C): 7,411 · Conversion (C): 6,947 · Conversion (C): 3,572,022 · +12 moreEDGAR
2022-10-264Prime Medicine, Inc. (PRME)Conversion (C): 4,124,375 · Conversion (C): 98,967 · Conversion (C): 11,015 · Conversion (C): 3,805,080 · Conversion (C): 423,509 · Conversion (C): 4,124,375 (derivative) · +4 moreEDGAR
2022-09-084Beam Therapeutics Inc. (BEAM)Other (J): 25,620 @ $0 · Other (J): 551 @ $0 · Sale (S): 551 @ $54.25EDGAR
2022-08-084Beam Therapeutics Inc. (BEAM)Other (J): 800,000 @ $0 · Other (J): 375,536 @ $0 · Other (J): 375,369 @ $0 · Other (J): 180,366 @ $0 · Other (J): 167,564 @ $0 · Other (J): 20,159 @ $0 · +3 moreEDGAR
2022-07-284Verve Therapeutics, Inc. (VERV)Holdings only — no transactions reportedEDGAR
2022-07-144Verve Therapeutics, Inc. (VERV)Sale (S): 100,000 @ $19.98 · Sale (S): 63,000 @ $22.04EDGAR
2022-07-064Verve Therapeutics, Inc. (VERV)Sale (S): 38,775 @ $15.66EDGAR
2022-07-014Verve Therapeutics, Inc. (VERV)Sale (S): 4,047 @ $15.50 · Sale (S): 30,362 @ $15.60 · Sale (S): 18,810 @ $15.21EDGAR
2022-04-144Beam Therapeutics Inc. (BEAM)Other (J): 978,503 @ $0 · Other (J): 509,490 @ $0 · Other (J): 509,332 @ $0 · Other (J): 137,845 @ $0 · Other (J): 128,333 @ $0 · Other (J): 15,406 @ $0 · +5 moreEDGAR
2022-03-114Verve Therapeutics, Inc. (VERV)Sale (S): 3,971 @ $29.01EDGAR
2022-02-114Verve Therapeutics, Inc. (VERV)Sale (S): 13,190 @ $29.46EDGAR
2022-02-034Verve Therapeutics, Inc. (VERV)Sale (S): 35,574 @ $29.04EDGAR
2022-01-284Verve Therapeutics, Inc. (VERV)Sale (S): 14,918 @ $29.67 · Sale (S): 88,989 @ $31.12 · Sale (S): 45,946 @ $31.96 · Sale (S): 8,736 @ $29.26 · Sale (S): 247 @ $30.02EDGAR
2021-11-124Toast, Inc. (TOST)Holdings only — no transactions reportedEDGAR
2021-10-284Xilio Therapeutics, Inc. (XLO)Conversion (C): 789,473 · Conversion (C): 686,499 · Conversion (C): 28,703 · Conversion (C): 372,215 · Conversion (C): 4,465 · Conversion (C): 7,500,000 (derivative) · +4 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=315066 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs